| Ellie Mental Health | |
|
24803 Detroit Rd Unit E Westlake OH 44145-2553 | |
| (216) 533-9677 | |
| Not Available |
| Full Name | Ellie Mental Health |
|---|---|
| Speciality | Clinic/Center |
| Location | 24803 Detroit Rd Unit E, Westlake, Ohio |
| Authorized Official Name and Position | Mark Ramunno (OWNER) |
| Authorized Official Contact | 2165339677 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ellie Mental Health 4591 W Point Dr Fairview Park OH 44126-2834 Ph: () - | Ellie Mental Health 24803 Detroit Rd Unit E Westlake OH 44145-2553 Ph: (216) 533-9677 |
| NPI Number | 1063148922 |
|---|---|
| Provider Enumeration Date | 07/25/2022 |
| Last Update Date | 03/31/2023 |
| Certification Date | 03/22/2023 |
| Medicare PECOS PAC ID | 8325413842 |
|---|---|
| Medicare Enrollment ID | O20230413002034 |
News Archive
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Parabit Systems Inc. is pleased to announce the successful installation of Secure Cares Infant Protection Systems in three major hospitals on Long Island.
The recent outbreaks of communicable diseases such as SARS and avian flu in particular, have prompted the United Nations health agency's policy-making body to adopt a new set of regulations concerning responses from Governments and international bodies when new diseases emerge and old ones reappear.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, highlights an overlooked relationship between migraine and exercise.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063148922 | NPI | - | NPPES |
| Provider Name | Laura Artino |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1306262845 PECOS PAC ID: 5799908711 Enrollment ID: I20140520002568 |
News Archive
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Parabit Systems Inc. is pleased to announce the successful installation of Secure Cares Infant Protection Systems in three major hospitals on Long Island.
The recent outbreaks of communicable diseases such as SARS and avian flu in particular, have prompted the United Nations health agency's policy-making body to adopt a new set of regulations concerning responses from Governments and international bodies when new diseases emerge and old ones reappear.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, highlights an overlooked relationship between migraine and exercise.
› Verified 8 days ago
| Provider Name | Tara M Pierce |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1467153189 PECOS PAC ID: 2365817889 Enrollment ID: I20230413002271 |
News Archive
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Parabit Systems Inc. is pleased to announce the successful installation of Secure Cares Infant Protection Systems in three major hospitals on Long Island.
The recent outbreaks of communicable diseases such as SARS and avian flu in particular, have prompted the United Nations health agency's policy-making body to adopt a new set of regulations concerning responses from Governments and international bodies when new diseases emerge and old ones reappear.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, highlights an overlooked relationship between migraine and exercise.
› Verified 8 days ago
| Provider Name | Lauren Michelle Mcgowan |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1780025023 PECOS PAC ID: 2860867389 Enrollment ID: I20240111002786 |
News Archive
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Parabit Systems Inc. is pleased to announce the successful installation of Secure Cares Infant Protection Systems in three major hospitals on Long Island.
The recent outbreaks of communicable diseases such as SARS and avian flu in particular, have prompted the United Nations health agency's policy-making body to adopt a new set of regulations concerning responses from Governments and international bodies when new diseases emerge and old ones reappear.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, highlights an overlooked relationship between migraine and exercise.
› Verified 8 days ago
| Provider Name | Jordin A Maria |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1811487523 PECOS PAC ID: 4981047222 Enrollment ID: I20240203000402 |
News Archive
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Parabit Systems Inc. is pleased to announce the successful installation of Secure Cares Infant Protection Systems in three major hospitals on Long Island.
The recent outbreaks of communicable diseases such as SARS and avian flu in particular, have prompted the United Nations health agency's policy-making body to adopt a new set of regulations concerning responses from Governments and international bodies when new diseases emerge and old ones reappear.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, highlights an overlooked relationship between migraine and exercise.
› Verified 8 days ago
News Archive
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
Parabit Systems Inc. is pleased to announce the successful installation of Secure Cares Infant Protection Systems in three major hospitals on Long Island.
The recent outbreaks of communicable diseases such as SARS and avian flu in particular, have prompted the United Nations health agency's policy-making body to adopt a new set of regulations concerning responses from Governments and international bodies when new diseases emerge and old ones reappear.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
A recent study published in the journal Cephalalgia, the official journal of the International Headache Society, highlights an overlooked relationship between migraine and exercise.
› Verified 8 days ago
The Intuitive Eating Center Of Northeast Ohio Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 24500 Center Ridge Rd Ste 265, Westlake, OH 44145 Phone: 216-395-4118 | |
Cleveland Behavioral Health Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 30628 Detroit Rd Ste 125, Westlake, OH 44145 Phone: 440-821-0051 | |
North Coast Psychological Services, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 24500 Center Ridge Rd, Bldg 4, Suite 120, Westlake, OH 44145 Phone: 440-899-1300 | |
Arbor Sana Counseling & Wellness Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 671 Columbia Rd Ste 8, Westlake, OH 44145 Phone: 440-895-0366 Fax: 440-331-2692 | |
Westlake America Clinic Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 25125 Detroit Rd Ste 100, Westlake, OH 44145 Phone: 216-293-0282 Fax: 440-455-9757 | |
Tiffany Manrodt Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 24481 Detroit Rd Ste 201, Westlake, OH 44145 Phone: 440-310-6361 Fax: 440-625-2592 | |
Aba & Beyond Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 23607 Belmont Dr, Westlake, OH 44145 Phone: 216-212-5758 |